Contributor #H-4102
Anonymous submitter. Two-lab confirmation as standard practice.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.25%
n=10
Suppliers covered
8
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042014 | GHRP-6 | AMB | AMB-2603-S5667 | PeptideMeter | 2026-Q3 | 99.24 | 6.62 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041959 | Sermorelin | AMB | AMB-2512-V5420 | Kestrel | 2026-Q2 | 99.26 | 3.91 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042717 | Mazdutide | ERP | ERP-2603-D1065 | PeptideMeter | 2026-Q2 | 97.68 | 3.85 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043559 | Liraglutide | SIG | SIG-2508-6459 | VendorInvestigate | 2026-Q1 | 97.66 | 5.90 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018990 | Enclomiphene citrate | ASY | ASY-{CAT}-1806 | Janoshik | 2025-Q4 | 99.93 | 3.59 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-021034 | BPC-157 | BCH | BCH-2506-D4413 | PeptideMeter | 2025-Q4 | 99.47 | 5.87 | 93.8 | Supplier-supplied | 0 | PASS |
| AX-2025-019847 | Semaglutide | Homopeptide | HOMO-2506-M5731 | VendorInvestigate | 2025-Q3 | 97.36 | 6.04 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020948 | BPC-157 | WXT | WXT-2501-J3079 | Nordanalyt | 2025-Q1 | 98.73 | 5.84 | 92.7 | Buyer-sourced | 0 | PASS |
| AX-2025-020189 | BPC-157 | ERP | ERP-2502-P9890 | Janoshik | 2025-Q1 | 99.79 | 4.27 | 94.2 | Buyer-sourced | 0 | PASS |
| AX-2025-021178 | SS-31 (Elamipretide) | PPG | PPG-2411-D6795 | Janoshik | 2025-Q1 | 99.71 | 6.18 | — | Buyer-sourced | 0 | PASS |